FDA Cancer Trial Modernization

FDA Guidance: Expansion Cohort Trials Expected to Modernize Oncology Trials

Sep 8, 2018 | FDA, FDA Cancer Trial Modernization, Oncology

Leah Lawrence of Cancer Therapy Advisor reports that The US Food and Drug Administration (FDA) released a draft guidance for industry that provided advice on designing and conducting adaptive clinical trials that would allow companies and researchers to assess...

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

159 WEST BROADWAY SUITE 200
SALT LAKE CITY, UT 84101

FDA Guidance: Expansion Cohort Trials Expected to Modernize Oncology Trials

Pin It on Pinterest